Following detection of small particles in flu vaccination batches of Agrippal and Fluad, initially Switzerland, Austria and Italy raised concerns and proposed to ban the vaccinations manufactured by Novartis. Recent reports suggest that even France, Germany and Spain have backed the proposal.
France Health Minister Marisol Touraine recalled all Agrippal vaccinations from the market. However, at the same time she notified that none of the patients subjected to the vaccination pose any risk.
While on the other hand, even Germany has followed the footsteps of France and stated that it will be calling off four batches of Agrippal and also a batch of Fluad vaccine will be recalled.
Similar to France, even Germany's Paul Ehrlich Institute, the vaccines division of the Ministry of Health, affirmed that although there have been no reports regarding any negative impact of the vaccines in patients using it, it is better to ban them amid safety concerns.
Professor Klaus Cichutek, President of the Institute, said: "In the interests of risk management and the safety of consumers, it is necessary to withdraw approval for certain batches of vaccines, as particles have been found in the vaccines".
Prof Cichutek claimed that there are high possibilities that the vaccinations might cause severe side-effects, which cannot be ignored.
Today's popular content
- Repsol board sanctions dividend cut
- Traffic at Gibraltar-Spain border now flowing normally
- 3 Seamen Found Dead, Two Missing as Fishing Boat Capsizes off Spain’s Northern Coast
- Spanish Political Parties Announce Candidate List for European Elections
- Huertas to Provide New York the Taste of Northern Spain
- Spain Probing into Alleged 1.5bn embezzlement of EU funds
- Spain has Second-Highest Child Poverty Rate in EU: Caritas Europa’s Report
- ‘Dragon’ corpse mystifies experts
- Solar Energy is Best Remedy for Air Pollution Problems in China
- Gardai Arrest 9 Men in Drugs and Arms Search Operation